Crossref
Pioglitazone Improves Survival In Patients With Cancer: The Hypothesis
Endocrine Oncology and Metabolism · 2015
DOI: 10.21040/eom/000004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrine Oncology and Metabolism, 2015. Verfasst von Banshi Saboo und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Saboo, B., Kruljac, I., & Rahelić, D. (2015). Pioglitazone Improves Survival In Patients With Cancer: The Hypothesis. Endocrine Oncology and Metabolism. https://doi.org/10.21040/eom/000004
Vancouver
Saboo B, Kruljac I, Rahelić D. Pioglitazone Improves Survival In Patients With Cancer: The Hypothesis. Endocrine Oncology and Metabolism. 2015. doi:10.21040/eom/000004
BibTeX
@article{Saboo2015,
author = {Saboo, Banshi and Kruljac, Ivan and Rahelić, Dario},
title = {Pioglitazone Improves Survival In Patients With Cancer: The Hypothesis},
journal = {Endocrine Oncology and Metabolism},
year = {2015},
doi = {10.21040/eom/000004}
}
EUVIMED